| Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study K Al Sulaiman, HA Badreldin, GB Korayem, AA Alenazi, F Alsuwayyid, ... Thrombosis Journal 20 (1), 25, 2022 | 12 | 2022 |
| Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice M Aldhaeefi, HA Badreldin, F Alsuwayyid, T Alqahtani, O Alshaya, ... Pharmacy 11 (1), 34, 2023 | 9 | 2023 |
| Evaluation of apixaban in patients with antiphospholipid syndrome: A case series and review of literature K Al Sulaiman, A Hafiz, HA Badreldin, GB Korayem, F Alsuwayyid, ... Journal of Investigative Medicine High Impact Case Reports 10, 23247096221099893, 2022 | 5 | 2022 |
| Apixaban use in patients with protein C and S deficiency: a case series and review of literature K Al Sulaiman, F Alsuwayyid, A Alrashidi, M Alhijris, F Almutairi, F Alharthi, ... Journal of Blood Medicine, 105-111, 2022 | 4 | 2022 |
| Effects of nanoparticle deformability on multiscale biotransport HH Gadalla, Z Yuan, Z Chen, F Alsuwayyid, S Das, H Mitra, AM Ardekani, ... Advanced Drug Delivery Reviews, 115445, 2024 | | 2024 |
